Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Products

Products methodology · Purity focus 6 products methodology → Product Top vendors Vendors Tests Latest Retatrutide 1Peptide Partners 92% 2Inno Peptides 91% 3ZLZ Peptide 91% 250 3,619 5 Aug 2026 Tirzepatide 1Yiwu Aozuo Trading Co 92% 2SRY Labs 92% 3Andy Peps Studio 92% 186 2,371 5 Aug 2026 BPC-157 1HK Peptides 78% 2LiliPeptide 72% 3Zenith Jove Peptide ZJ 70% 108 743 5 Aug 2026 Semaglutide 1Peptide Crafters 84% 2Paramount Peptides 82% 3Skye Peptides 82% 57 339 23 Jul 2026 CJC-1295 1Yimei 49% 2HXNet 49% 3ZLZ Peptide 46% 54 288 13 Jul 2026 Melanotan II 1Injectify 72% 2Deuschem 72% 3Atomik Labz 71% 40 170 10 Jul 2026

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Products

methodology · Purity focus

6 products

methodology →

Product Top vendors Vendors Tests Latest Retatrutide

1Peptide Partners

92%

2Inno Peptides

91%

3ZLZ Peptide

91% 250 3,619 5 Aug 2026 Tirzepatide

1Yiwu Aozuo Trading Co

92%

2SRY Labs

92%

3Andy Peps Studio

92% 186 2,371 5 Aug 2026 BPC-157

1HK Peptides

78%

2LiliPeptide

72%

3Zenith Jove Peptide ZJ

70% 108 743 5 Aug 2026 Semaglutide

1Peptide Crafters

84%

2Paramount Peptides

82%

3Skye Peptides

82% 57 339 23 Jul 2026 CJC-1295

1Yimei

49%

2HXNet

49%

3ZLZ Peptide

46% 54 288 13 Jul 2026 Melanotan II

1Injectify

72%

2Deuschem

72%

3Atomik Labz

71% 40 170 10 Jul 2026

Connected topics

Follow this recovery question